Tokyo, Japan

Yasuhiro Kotani

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yasuhiro Kotani: Innovator in Keratoconjunctival Health

Introduction

Yasuhiro Kotani is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of ophthalmology, particularly in the development of protective agents for the keratoconjunctiva. His innovative work has the potential to improve the quality of life for individuals suffering from keratoconjunctival disorders.

Latest Patents

Yasuhiro Kotani holds a patent for a protective agent for the keratoconjunctiva or a suppressive agent for keratoconjunctival disorders. The patent, which is focused on the use of glucosylglycerol as an active ingredient, aims to provide an excellent suppressive effect on keratoconjunctival disorders. This invention not only highlights the therapeutic potential of glucosylglycerol but also offers a method for protecting the keratoconjunctiva through its administration.

Career Highlights

Throughout his career, Yasuhiro Kotani has worked with prominent companies in the pharmaceutical and sugar refining industries. Notable among these are Toyo Sugar Refining Co., Ltd. and Otsuka Pharmaceutical Factory, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for health-related challenges.

Collaborations

Yasuhiro Kotani has collaborated with esteemed colleagues such as Kyo Aizawa and Yoshihisa Iida. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Yasuhiro Kotani's contributions to the field of keratoconjunctival health through his innovative patent demonstrate his commitment to improving patient care. His work continues to inspire advancements in ophthalmology and highlights the importance of research in developing effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…